Title,Authors,Platform,Cited_url,Cited_count,Year
ldentification of the von Hippel-Lindau disease tumor suppressor gene,"F Latif, K Tory, J Gnarra, M Yao, FM Duh, ML Orcutt, T Stackhouse, ...","Science 260 (5112), 1317-1320","https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12900885100206896250,17138084281631696608,13448093896663685327,14148394631834013552,11395656741439774834",3000,1993
Familial gastric cancer: overview and guidelines for management*,"C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ...","Journal of Medical Genetics 36 (12), 873-880",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16532701614596505768,662,1999
"Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan","B Zbar, T Kishida, F Chen, L Schmidt, ER Maher, FM Richards, ...","Human mutation 8 (4), 348-357",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17560783906916897743,541,1996
Identification of intragenic mutations in the Von Hippel—Lindau disease tumour suppressor gene andcorrelation with disease phenotype,"PA Crossey, FM Richards, K Foster, A Prowse, F Latlf, MI Lerman, B Zbar, ...","Human molecular genetics 3 (8), 1303-1308",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14157223909404343444,393,1994
Somatic mutations of the von Hippel—Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma,"K Foster, A Prowse, A van den Berg, S Fleming, MMF Hulsbeek, ...","Human molecular genetics 3 (12), 2169-2173",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9531507793299363150,385,1994
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer,"FM Richards, SA McKee, MH Rajpar, TRP Cole, DGR Evans, ...","Human molecular genetics 8 (4), 607-610",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2733875094066502705,359,1999
Epigenetic inactivation of the RASSF1A 3p21. 3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma,"C Morrissey, A Martinez, M Zatyka, A Agathanggelou, S Honorio, D Astuti, ...","Cancer research 61 (19), 7277-7281",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4886016909048783231,251,2001
Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.,"AH Prowse, AR Webster, FM Richards, S Richard, S Olschwang, ...","American journal of human genetics 60 (4), 765",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13383182453233294827,251,1997
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.,"ER Maher, AR Webster, FM Richards, JS Green, PA Crossey, SJ Payne, ...","Journal of medical genetics 33 (4), 328-332",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17866812105133191681,225,1996
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands,"G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ...","Human molecular genetics 12 (5), 575-582",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15814869308541062436,174,2003
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a …,"M Zatyka, NF da Silva, SC Clifford, MR Morris, MS Wiesener, KU Eckardt, ...","Cancer research 62 (13), 3803-3811",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6836618061145044205,169,2002
"Zebrafish based assays for the assessment of cardiac, visual and gut function—potential safety screens for early drug discovery","S Berghmans, P Butler, P Goldsmith, G Waldron, I Gardner, Z Golder, ...","Journal of pharmacological and toxicological methods 58 (1), 59-68",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11108222795364673403,168,2008
Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours,"PA Crossey, K Foster, FM Richards, ME Phipps, F Latif, K Tory, MH Jones, ...","Human genetics 93 (1), 53-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1649058002727247601,149,1994
Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene,"FM Richards, SJ Payne, B Zbar, NA Affara, MA Ferguson-Smith, ...","Human molecular genetics 4 (11), 2139-2143",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12982074539205710545,123,1995
"Cyclosporine, FK506, and rapamycin: some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells","SM METCALFE, FM RICHARDS","Transplantation 49 (4), 798-802",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17837857992104700098,123,1990
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice,"A Neesse, KK Frese, DS Chan, TE Bapiro, WJ Howat, FM Richards, ...","Gut 63 (6), 974-983",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3015991136923327180,120,2014
"Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22","K Foster, PA Crossey, P Cairns, JW Hetherington, FM Richards, ...","British journal of cancer 69 (2), 230-234",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17709591149789092552,117,1994
Expression of the Von Hippel—Lindau Disease Tumour Suppressor Gene during Human Embryogenesis,"FM Richards, PN Schofield, S Fleming, ER Maher","Human molecular genetics 5 (5), 639-644",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4334768876966496237,115,1996
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer,"TR Porter, FM Richards, RS Houlston, DGR Evans, JA Jankowski, ...","Oncogene 21 (12), 1928",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7975402847070100744,113,2002
"Design, Synthesis, and Biological Evaluation of an Allosteric Inhibitor of HSET that Targets Cancer Cells with Supernumerary Centrosomes","CA Watts, FM Richards, A Bender, PJ Bond, O Korb, O Kern, M Riddick, ...","Chemistry & biology 20 (11), 1399-1410",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9374758659137855098,107,2013
An analysis of phenotypic variation in the familial cancer syndrome von Hippel–Lindau disease: evidence for modifier effects,"AR Webster, FM Richards, FE MacRonald, AT Moore, ER Maher","The American Journal of Human Genetics 63 (4), 1025-1035",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3893282636795828777,105,1998
Combenefit: an interactive platform for the analysis and visualization of drug combinations,"GY Di Veroli, C Fornari, D Wang, S Mollard, JL Bramhall, FM Richards, ...","Bioinformatics 32 (18), 2866-2868",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6172987225459385774,102,2016
Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae,"W Alderton, S Berghmans, P Butler, H Chassaing, A Fleming, Z Golder, ...","Xenobiotica 40 (8), 547-557",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=117179952789929045,100,2010
Molecular genetic analysis of von Hippel-Lindau disease.,"FM Richards, AR Webster, R McMahon, ER Woodward, S Rose, ...","Journal of internal medicine 243 (6), 527-533",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9415869017777102773,91,1998
Detailed mapping of germline deletions of the von Hippel—Lindau disease tumour suppressor gene,"FM Richards, PA Crossey, ME Phlpps, K Foster, F Latif, G Evans, ...","Human molecular genetics 3 (4), 595-598",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6401272987431666674,91,1994
VONHIPPEL-LINDAU SYNDROME-CLONING AND IDENTIFICATION OF THE PLASMA-MEMBRANE CA++-TRANSPORTING ATPASE ISOFORM-2 GENE THAT RESIDES IN THE VONHIPPEL-LINDAU GENE REGION,"F Latif, FM Duh, J Gnarra, K Tory, I Kuzmin, M Yao, T STACKHOUSE, ...","Cancer Research 53 (4), 861-867",,88,1993
Von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca++-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region,"F Latif, FM Duh, J Gnarra, K Tory, I Kuzmin, M Yao, T Stackhouse, W Modi, ...","Cancer research 53 (4), 861-867",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12092102352818654006,88,1993
"Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma","MR Morris, E Maina, NV Morgan, D Gentle, D Astuti, H Moch, T Kishida, ...","Journal of clinical pathology 57 (7), 706-711",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18158032367880074317,74,2004
Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo,"FM Richards, CJ Tape, DI Jodrell, G Murphy","PloS one 7 (7), e40597",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4666311371908694731,71,2012
Correlation between the conformational phenotype of p53 and its subcellular location.,"J Zerrahn, W Deppert, D Weidemann, T Patschinsky, F Richards, J Milner","Oncogene 7 (7), 1371-1381",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2335748971316121148,71,1992
Validation of the use of zebrafish larvae in visual safety assessment,"FM Richards, WK Alderton, GM Kimber, Z Liu, I Strang, WS Redfern, ...","Journal of pharmacological and toxicological methods 58 (1), 50-58",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11841750145927208831,69,2008
An automated fitting procedure and software for dose-response curves with multiphasic features,"GY Di Veroli, C Fornari, I Goldlust, G Mills, SB Koh, JL Bramhall, ...","Scientific reports 5, 14701",,65,2015
An automated fitting procedure and software for dose-response curves with multiphasic features.,"GY Veroli, C Fornari, I Goldlust, G Mills, SB Koh, JL Bramhall, ...","Scientific reports 5, 14701-14701",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13363724148788589843,65,2014
DETAILED GENETIC-MAPPING OF THE VONHIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR GENE,"FM Richards, ER Maher, F Latif, ME Phipps, K Tory, M Lush, PA Crossey, ...","JOURNAL OF MEDICAL GENETICS 30 (2), 104-107",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9506607936157720499,64,1993
Mapping the Von Hippel—Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis,"FM Richards, ME Phipps, F Latlf, M Yao, PA Crossey, K Foster, ...","Human molecular genetics 2 (7), 879-882",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=101857207854174120,62,1993
Molecular pathology of von Hippel–Lindau disease and the VHL tumour suppressor gene,FM Richards,"Expert reviews in molecular medicine 3 (08), 1-27",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5043247038663670243,61,2001
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer,"E Hessmann, MS Patzak, L Klein, N Chen, V Kari, I Ramu, TE Bapiro, ...","Gut 67 (3), 497-507",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5060538221402879094,55,2018
von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis,"M Yao, F Latif, ML Orcutt, I Kuzmin, T Stackhouse, F wei Zhou, K Tory, ...","Human genetics 92 (6), 605-614",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15912171881775274030,52,1993
Investigation of the effects of heat shock and agents which induce a heat shock response on the induction of differentiation of HL-60 cells,"FM Richards, A Watson, JA Hickman","Cancer research 48 (23), 6715-6720",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1283159024219658814,52,1988
Identification of novel VHL target genes and relationship to hypoxic response pathways,"EN Maina, MR Morris, M Zatyka, RR Raval, RE Banks, FM Richards, ...","Oncogene 24 (28), 4549-4558",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3980448312558049911,50,2005
Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes,"FM Richards, DR Goudie, WN Cooper, Q Jene, I Barroso, C Wicking, ...","Human genetics 101 (3), 317-322",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16749182640427428392,49,1997
Genetic linkage between Von Hippel—Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus,"PA Crossey, ER Maher, MH Jones, FM Richards, F Latif, ME Phipps, ...","Human molecular genetics 2 (3), 279-282",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6358626069913342332,47,1993
Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma,"EF Carapuça, E Gemenetzidis, C Feig, TE Bapiro, MD Williams, ...","The Journal of pathology 239 (3), 286-296",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3216311867029961756,46,2016
CHK1 inhibition synergizes with gemcitabine initially by destabilizing the DNA replication apparatus,"SB Koh, A Courtin, RJ Boyce, RG Boyle, FM Richards, DI Jodrell","Cancer research 75 (17), 3583-3595",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17436180792737140485,45,2015
"A novel method for quantification of gemcitabine and its metabolites 2′, 2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with …","TE Bapiro, FM Richards, MA Goldgraben, KP Olive, B Madhu, KK Frese, ...","Cancer chemotherapy and pharmacology 68 (5), 1243-1253",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4253102731021627071,42,2011
Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter,"M Zatyka, C Morrissey, I Kuzmin, MI Lerman, F Latif, FM Richards, ...","Journal of medical genetics 39 (7), 463-472",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1306831598771283780,37,2002
Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers.,"ER Maher, E Bentley, SJ Payne, F Latif, FM Richards, M Chiano, S Hosoe, ...","Journal of medical genetics 29 (12), 902-905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15361581197054630044,31,1992
Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer,"A Courtin, FM Richards, TE Bapiro, JL Bramhall, A Neesse, N Cook, ...","PloS one 8 (6), e67330",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18291367463346125934,26,2013
"Paclitaxel and CYC3, an aurora kinase A inhibitor, synergise in pancreatic cancer cells but not bone marrow precursor cells","Y Lin, FM Richards, BF Krippendorff, JL Bramhall, JA Harrington, ...","British journal of cancer 107 (10), 1692-1701",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2236685049609338469,26,2012
MET mutation and familial gastric cancer,"JD Chen, S Kearns, T Porter, FM Richards, ER Maher, BT Teh","Journal of medical genetics 38 (8), e26-e26",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5912549756837158703,25,2001
Identification of novel VHL targets that are associated with the development of renal cell carcinoma,"M Abdulrahman, EN Maina, MR Morris, M Zatyka, RR Raval, RE Banks, ...","Oncogene 26 (11), 1661-1672",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3461179340597495130,23,2007
"The elusive multiple self-healing squamous epithelioma (MSSE) gene: further mapping, analysis of candidates, and loss of heterozygosity","S Bose, LJ Morgan, DR Booth, DR Goudie, MA Ferguson-Smith, ...","Oncogene 25 (5), 806-812",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4179795281081489056,22,2006
"Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes","SC Clifford, K Czapla, FM Richards, DJ O'Donoghue, ER Maher","British journal of cancer 77 (9), 1420-1428",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17827157165936262268,22,1998
A PCR generated AccI RFLP in the 3′ untranslated region of the von Hippel—Lindau disease (VHL) tumour suppressor gene,"SJ Payne, FM Richards, ER Maher","Human molecular genetics 3 (2), 390-390",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8659322827123665096,22,1994
"Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin.","FM Richards, J Milner, S Metcalfe","Immunology 76 (4), 642",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2049512232922808488,19,1992
Understanding the Complexity of Porous Graphitic Carbon (PGC) Chromatography: Modulation of Mobile-Stationary Phase Interactions Overcomes Loss of Retention and Reduces Variability,"TE Bapiro, FM Richards, DI Jodrell","Analytical chemistry 88 (12), 6190-6194",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16067730679154462907,16,2016
GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utility,"P Goldsmith, Z Golder, J Hunt, S Berghmans, D Jones, JP Stables, ...","Pharmacology 79 (4), 250-258",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9174050557795092735,12,2007
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo,"TE Bapiro, KK Frese, A Courtin, JL Bramhall, B Madhu, N Cook, A Neesse, ...","British journal of cancer 111 (2), 318-325",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6894820734449805184,11,2014
The ATR inhibitor AZD6738 synergizes with gemcitabine in vitro and in vivo to induce pancreatic ductal adenocarcinoma regression,"Y Wallez, CR Dunlop, TI Johnson, SB Koh, C Fornari, JWT Yates, ...","Molecular cancer therapeutics 17 (8), 1670-1682",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8411172387635316218,10,2018
A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level,"SB Koh, P Mascalchi, E Rodriguez, Y Lin, DI Jodrell, FM Richards, ...","J Cell Sci 130 (2), 512-520",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=254508046956447808,10,2017
Mechanistic distinctions between CHK1 and WEE1 inhibition guide the scheduling of triple therapy with gemcitabine,"SB Koh, Y Wallez, CR Dunlop, SB de Quirós Fernández, TE Bapiro, ...","Cancer research 78 (11), 3054-3066",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=960234659727856227,9,2018
TaqI and PstI RFLPs in the von Hippel-Lindau disease gene (VHL).,"FM Richards, F Latif, MI Lerman, B Zbar, ER Maher","Human molecular genetics 2 (10), 1750",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5079888427992557503,8,1993
Investigations of the relationship between cell proliferation and differentiation of HL-60 cells induced to differentiate by N-methylformamide,"SP Langdon, FM Richards, JA Hickman","Leukemia research 12 (3), 211-216",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14768153097391624791,8,1988
The EGFR demonstrates linear signal transmission,"DA Oyarzún, JL Bramhall, F López-Caamal, FM Richards, DI Jodrell, ...","Integrative Biology 6 (8), 736-742",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15176493029213559685,6,2014
Germline mutation analysis of the transforming growth factor β receptor type II (TGFBR2) and E-cadherin (CDH1) genes in early onset and familial colorectal cancer,"L VERMA, TR PORTER, FM RICHARDS, MH RAJPAR, RE D GARETH, ...","Journal of medical genetics 38 (2), e7-e7",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2258523673706265456,6,2001
Electronic letters-Germline mutation analysis of the transforming growth factor b receptor type II (TGFBR2) and E-cadherin (CDHI) genes in early onset and familial colorectal …,"L Verma, TR Porter, FM Richards, MH Rajpar, DGR Evans, F Macdonald, ...","Journal of Medical Genetics 38 (2), E7",,6,2001
Treatment of Macular Degeneration,"FM Richards, AG Roach","US Patent App. 12/520,715",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3042951615669579243,4,2010
Prediction of ophthalmic effects in man by screening drugs for the optokinetic and optomotor responses in zebrafish,"FM Richards, G Kimber, P Butler, G Waldron, T Knight, P Goldsmith, ...","Investigative Ophthalmology & Visual Science 47 (13), 2622-2622",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2608441570384735033,4,2006
Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy,"RC Jackson, GY Di Veroli, SB Koh, I Goldlust, FM Richards, DI Jodrell","PLOS Computational Biology 13 (5), e1005529",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13404414637144106533,3,2017
Detailed genetic mapping of the von Hippel-Lindau disease.,FM Richards,"J Med Genet 29, 902-905",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7388016079978992420,3,1992
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells.,"S Metcalfe, J Milner, FM Richards","Transplantation proceedings 22 (4), 1547-1548",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1212629597199644379,3,1990
Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites,"MS Patzak, V Kari, S Patil, FH Hamdan, RG Goetze, M Brunner, ...","EBioMedicine 40, 394-405",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6059015828799091008,2,2019
Germline E-cadherin gene mutations in familial gastric cancer,"FM Richards, SA McKee, TRP Cole, DRG Evans, JA Jankowski, ...","Journal of Medical Genetics 35 (1S), 24S",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15350013765658720187,2,1998
Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade,"R Xu, F M Richards","Combinatorial chemistry & high throughput screening 20 (5), 451-457",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10880485191085331804,1,2017
Abstract B54: Genetically engineered mouse-derived allografts (GEDAs): an immunocompetent mouse model of PDAC for the evaluation of novel therapeutic strategies,"S Mollard, KK Frese, A Gopinathan, FM Richards, DI Jodrell","Cancer Research 76 (24 Supplement), B54-B54",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13768224235747398259,1,2016
The E-cadherin (CDH1) gene in familial gastric cancer and in early onset colorectal cancer,"T Porter, FM Richards, L Verma, DSA Sanders, JA Jankowski, TRP Cole, ...","JOURNAL OF MEDICAL GENETICS 36, S43-S43",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7124486442859015945,1,1999
SP53 Clinical features of Familial Gastric Cancer,"FM Richards, S Iskander-Gabra, TRP Cole, DGR Evans, K Hosie, ...","Journal of Medical Genetics 34 (9S), 26S",,1,1997
Clinical features of familial gastric cancer,"FM Richards, S IskanderGabra, TRP Cole, DGR Evans, K Hosie, ...","JOURNAL OF MEDICAL GENETICS 34, SP53-SP53",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6545981344442757228,1,1997
MOLECULAR-GENETIC ANALYSIS IN THE MANAGEMENT OF VONHIPPEL-LINDAU (VHL) DISEASE,"ER Maher, FM RICHARDS, PA CROSSEY, F LATIF, K FOSTER, ...","American Journal of Human Genetics 53 (3), 16-16",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14986334815345054461,1,1993
Estimation by FACS of the delivery of liposome encapsulated macromolecules into myeloid cells,"HO Alpar, AM Bason, JA Hickman, FM Richards, WN Field","International Journal of Pharmaceutics 62 (2), 133-141",https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15688028642778443621,1,1990
The role of ATM and DNA-PK in responding to AZD6738-induced damage in pancreatic ductal adenocarcinoma cells,"CR Dunlop, Y Wallez, SB de Quirós Fernández, SA Karim, A Lau, ...","Cancer Research 79 (13 Supplement), 271-271",,0,2019
Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors,"MJ Sale, E Minihane, NR Monks, R Gilley, FM Richards, KP Schifferli, ...",Nature Publishing Group,,0,2019
"Po-261 multimodal mass spectrometry imaging to understand drug delivery, metabolism, response and amp; resistance in pancreatic ductal adenocarcinoma.","S Ling, G Hamm, Y Wallez, FM Richards, IT Johnson, CR Dunlop, ...","ESMO Open 3 (Suppl 2), A329-A329",,0,2018
Impact of cytosolic 5'-nucleotidase 1A on chemotherapeutic resistance in pancreatic cancer,"MS Patzak, E Hessmann, V Kari, J Kitz, S Patil, FM Richards, DI Jodrell, ...","Pancreatology 18 (4), S91",,0,2018
Overall cellularity but not acellular stroma deposition increases gemcitabine accumulation in a genetically engineered mouse model of pancreatic cancer,"I Ramu, R Goetze, M Patzak, P Ströbel, B Sipos, F Richards, D Jodrell, ...","Pancreatology 18 (4), S70-S71",,0,2018
Tumor associated macrophages (TAMs) scavenge gemcitabine but not 5-FU and paclitaxel in pancreatic cancer,"SM Buchholz, R Goetze, M Patzak, F Richards, D Jodrell, H Griesmann, ...","Pancreatology 18 (4), S148-S149",,0,2018
Metabolic Reprogramming of Fibroblasts to Enhance Gemcitabine Availability in Murine Pancreatic Cancer,"MS Patzak, E Hessmann, V Kari, FM Richards, DI Jodrell, SA Johnsen, ...","Pancreatology 17 (3), S13",,0,2017
Using a genome-wide shRNA screen to investigate the mechanism of stroma-conferred gemcitabine resistance in pancreatic ductal adenocarcinoma,"GD Mills, N Erard, FM Richards, GJ Hannon, DI Jodrell","Cancer Research 77 (13 Supplement), 3190-3190",,0,2017
"The ATR inhibitor, AZD6738, synergizes with other DNA damage response inhibitors and genotoxic drugs in pancreatic ductal adenocarcinoma cell lines: Opportunities for new …","Y Wallez, SB Koh, VSV Bhogadi, A Lau, FM Richards, DI Jodrell",MOLECULAR CANCER RESEARCH 15,,0,2017
"Abstract B19: The ATR inhibitor, AZD6738, synergizes with other DNA damage response inhibitors and genotoxic drugs in pancreatic ductal adenocarcinoma cell lines: Opportunities …","Y Wallez, SB Koh, VSV Bhogadi, A Lau, FM Richards, DI Jodrell","Molecular Cancer Research 15 (4 Supplement), B19-B19",,0,2017
Abstract B40: Evaluation of the combination of AZD2014 and olaparib in pancreatic cancer cells,"A Gopinathan, FM Richards, S Cosulich, B Basu, DI Jodrell","Cancer Research 76 (24 Supplement), B40-B40",,0,2016
Abstract B62: Evaluation of scheduling for triple therapy gemcitabine/CHEK1 inhibitor/WEE1 inhibitor in pancreatic cancer models,"SB Koh, FM Richards, Y Wallez, DI Jodrell","Cancer Research 76 (24 Supplement), B62-B62",,0,2016
Genetically engineered mouse-derived allografts (GEDAs): an immunocompetent mouse model of PDAC for the evaluation of novel therapeutic strategies,"S Mollard, KK Frese, A Gopinathan, FM Richards, DI Jodrell",CANCER RESEARCH 76,,0,2016
"The dual mTOR inhibitor, AZD2014, and castration increase intra-tumoral immune cell infiltration and anti-tumour activity in a genetically engineered mouse model of prostate cancer","C Sandi, A Ramos-Montoya, SL Filisbino, A Hughes, S Mosely, M Morrow, ...","Cancer Research 76 (14 Supplement), 389-389",,0,2016
Developing drug combinations to co-target pancreatic cancer and its supporting stroma,"EF Carapuça, E Gemenetzidis, C Feig, TE Bapiro, MD Williams, ...","Pancreatology 16 (3), S4",,0,2016
Gemcitabine delivery and stromal component analysis in primary murine pancreatic tumours and liver metastasis,"L Klein, E Hessmann, TE Bapiro, K Frese, FM Richards, DI Jodrell, ...","Pancreatology 16 (3), S17",,0,2016
"Abstract A123: Preclinical evaluation of dual mTOR inhibitor, AZD2014, in prostate cancer","C Sandi, A Ramos-Montoya, SL Felisbino, S Jurmeister, B Madhu, ...","Molecular Cancer Therapeutics 14 (12 Supplement 2), A123-A123",,0,2015
"Preclinical Evaluation of Dual mTOR Inhibitor, AZD2014, in Prostate Cancer","C Sandi, A Ramos-Montoya, SL Filisbino, S Jurmeister, M Basetti, ...",American Association for Cancer Research,,0,2015
"A new mathematical model and software, to enable improved quantification and interpretation of combinatorial drug effects","GY Di Veroli, DI Jodrell, FM Richards, I Goldlust","Cancer Research 75 (15 Supplement), 2540-2540",,0,2015
Mechanism-based scheduling of triple therapy gemcitabine/CHK1i/WEE1i in pancreatic cancer at submaximal yet synergistic concentrations,"SB Koh, FM Richards, E Rodriguez, SK Lyons, DI Jodrell","Cancer Research 75 (15 Supplement), 3497-3497",,0,2015
Mst2 is required for tumor progression and Yap activity,"C Escriu, K Mulder, S Woodhouse, N Benaich, S Broad, F Richards, ...","Cancer Research 74 (19 Supplement), 2016-2016",,0,2014
An in vitro fluorescence-based co-culture model identifies tumour microenvironment-mediated chemoresistance in pancreatic cancer,"R Xu, FM Richards, Y Lin, DI Jodrell","Cancer Research 74 (19 Supplement), 3739-3739",,0,2014
Pancreatic cancer,"A Neesse, KK Frese, DS Chan, TE Bapiro, WJ Howat, FM Richards, ...","Gut 63 (9), 1481-1489",,0,2014
32 Replication stress is a determinant of synergy between gemcitabine and Chk1 inhibition,"SB Koh, A Courtin, R Boyce, B Boyle, FM Richards, DI Jodrell","European Journal of Cancer 50, 16",,0,2014
"Design, synthesis and biological evaluation of a novel allosteric inhibitor of HSET that damages cancer cells with supernumerary centrosomes.","CA Watts, FM Richards, A Bender, PJ Bond, O Korb, O Kern, M Riddick, ...",Molecular Cancer Therapeutics 12 (11),,0,2013
"Abstract B96: Design, synthesis and biological evaluation of a novel allosteric inhibitor of HSET that damages cancer cells with supernumerary centrosomes.","CA Watts, FM Richards, A Bender, PJ Bond, O Korb, O Kern, M Riddick, ...","Molecular Cancer Therapeutics 12 (11 Supplement), B96-B96",,0,2013
Abstract IA13: How much gemcitabine reaches the target… and does it matter?,"DI Jodrell, T Bapiro, N Cook, K Frese, M Jacobetz, A Neesse, F Richards, ...","Cancer Research 72 (14 Supplement), IA13-IA13",,0,2012
A detailed structural and functional analysis of VHL mutations and their effects on hypoxia inducible factor-α in sporadic clear cell renal carcinoma: Number 1: Young …,"L Gossage, M Bycroft, F Richards, T Eisen",Bju International 109,,0,2012
The aurora kinase inhibitor CYC3 synergizes with low concentrations of paclitaxel in pancreatic cancer cells in vitro,"Y Lin, BF Krippendorff, J Bramhall, T Bapiro, F Richards, D Jodrell, ...","Cancer Research 72 (8 Supplement), 1924-1924",,0,2012
"Activity of the specific anti-ADAM17 inhibitory IgG antibody (Ab), D1 (A12) in an ovarian cancer model in vivo","FM Richards, C Tape, DI Jodrell, G Murphy","Cancer Research 72 (8 Supplement), 2724-2724",,0,2012
Capecitabine pharmacokinetics and efficacy in spontaneous tumors occurring in a genetically engineered mouse model (GEMM) of pancreatic cancer,"A Courtin, FM Richards, TE Bapiro, DM Smith, M Williams, JL Bramhall, ...","Cancer Research 72 (8 Supplement), 3771-3771",,0,2012
"Discovery, design and synthesis of a novel series of non-peptidomimetic inhibitors of XIAP-caspase 9 interactions","DM Allwood, RM Myers, F Richards, A Bender, C Watts, SV Ley",ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 243,,0,2012
The activity and pharmacokinetics of capecitabine in a mouse model (K8484) of pancreatic adenocarcinoma,"FM Richards, A Courtin, TE Bapiro, JL Bramhall, N Cook, KK Frese, ...","Cancer Research 71 (8 Supplement), 5446-5446",,0,2011
Identification Of Novel VHL Targets That Are Associated With The Development Of Renal Cell Carcinoma.,"MR Morris, MS Wiesener, ER Maher, CM Johnson, RE Banks, ...",,,0,2007
Identification Of Novel VHL Targets That Are Associated With The Development Of Renal Cell Carcinoma.,"ER Maher, F Latif, CM Johnson, FM Richards, MS Wiesener, RE Banks, ...",,,0,2007
P1 Development Of A Mptp Model Of Parkinson's Disease In Zebrafish,"J Salzmann, O Anichtchik, J Best, F Richards, A Fleming, A Roach, ...","Behavioural Pharmacology 17 (5-6), 541",,0,2006
Identification of Novel VHL Target Genes and Relationship to Hypoxic Response Pathways,"EN Maina, MR Morris, M Zatyka, RR Raval, RE Banks, FM Richards, ...","The Journal of Urology 175 (1), 387",,0,2006
"Molecular Genetic Analysis Of FIH-1, FH, And SDHB Candidate Tumour Suppressor Genes In Renal Cell Carcinoma.","H Moch, MR Morris, D Astuti, NV Morgan, P Schraml, ER Maher, D Gentle, ...",,,0,2004
"Molecular Genetic Analysis Of FIH-1, FH, And SDHB Candidate Tumour Suppressor Genes In Renal Cell Carcinoma.","ER Maher, F Latif, FM Richards, P Schraml, M Yao, T Kishida, H Moch, ...",,,0,2004
Mono-allelic expression of PTCH in BCC from patients with Gorlin syndrome,"C Bruce, FM Richards, PA Farndon","JOURNAL OF MEDICAL GENETICS 41, S78-S78",,0,2004
Identification of CDH1 germline mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Human Molecular Genetics 12: 575-582.,"G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ...",,,0,2003
Identification of cyclin D1 (CCND1) and other novel targets for the VHL tumour suppressor gene (TSG) and investigation of CCND1 genotype as a modifier in VHL disease.,"M Zatyka, NF da Silva, SC Clifford, MR Morris, MS Wiesener, KU Eckardt, ...","AMERICAN JOURNAL OF HUMAN GENETICS 71 (4), 238-238",,0,2002
FIH-1 mutation analysis in sporadic RCCs and Gliomas,"E Maina, FM Richards, C Eng, ER Maher","JOURNAL OF MEDICAL GENETICS 39, S74-S74",,0,2002
Identification of cyclin D1 (CCND1) as a novel target for the VHL tumour suppressor gene (TSG) and investigation of CCND1 genotype as a modifier in von Hippel-Lindau (VHL) disease,"NF da Silva, M Zatyka, SC Clifford, MR Morris, MS Wiesener, RS Houlston, ...","JOURNAL OF MEDICAL GENETICS 39, S72-S72",,0,2002
Molecular Biology and Genetics-Identification of Cyclin D1 and Other Novel Targets for the von Hippel-Lindau Tumor Suppressor Gene by Expression Array Analysis and …,"M Zatyka, N Fernandes da Silva, SC Clifford, MR Morris, MS Wiesener, ...","Cancer Research 62 (13), 3803-3811",,0,2002
Epigenetic inactivation of the RASSF1A tumour suppressor gene (TSG) in renal cell carcinoma.,"C Morrissey, A Martinez, M Zatyka, A Agathanggelou, P Schraml, ...","AMERICAN JOURNAL OF HUMAN GENETICS 69 (4), 266-266",,0,2001
Epigenetic inactivation of the RASSF1A 3p21. 3 tumour PCR suppressor gene in both clear cell and papillary renal cell carcinoma,"C Morrissey, A Martinez, M Zatyka, T Kishida, M Yao, P Schrami, ...","JOURNAL OF MEDICAL GENETICS 38, S59-S59",,0,2001
Natural history of Gorlin syndrome and the spectrum of mutations in the PTCH gene,"P Farndon, CA Hardy, SJ Rooker, P Fullwood, FM Richards","JOURNAL OF MEDICAL GENETICS 37, S64-S64",,0,2000
Genetic and functional analysis of the VHL tumour suppressor gene promoter,"C Morrissey, M Zatyka, F Latif, F Richards, E Maher","JOURNAL OF MEDICAL GENETICS 37, S89-S89",,0,2000
Mapping the Multiple Self-Healing Squamous Epithelioma (MSSE) gene: exclusion of Patched (PTCH) and Transforming growth factor beta receptor type I (TGFBR1) genes.,"S Bose, LJ Ward, DR Booth, MA Ferguson-Smith, FM Richards","JOURNAL OF MEDICAL GENETICS 37, S73-S73",,0,2000
JMG,"SM Powell, FR Lewis, DG Huntsman, PDP Pharoah, JA Jankowski, ...",,,0,1999
"SM Powell, FR Lewis, DG Huntsman, PDP Pharoah, JA Jankowski, P MacLeod, H Vogelsang, G Keller, KGM Park","FM Richards, ER Maher, SA Gayther, C Oliveira, N Grehan, D Wight, ...",,,0,1999
Analysis of E-cadherin (CDH1) and transforming growth factor-beta type II receptor (TGFBR2) genes in genetic predisposition to early onset colorectal carcinoma.,"FM Richards, L Verma, TR Porter, DGR Evans, ER Maher","AMERICAN JOURNAL OF HUMAN GENETICS 65 (4), A318-A318",,0,1999
The spectrum of germline PATCHED mutations in UK families with naevoid basal cell carcinoma syndrome (Gorlin syndrome).,"SJ Rooker, C Hardy, P Fullwood, R Toftgard, P Kogerman, PA Farndon, ...","AMERICAN JOURNAL OF HUMAN GENETICS 65 (4), A10-A10",,0,1999
Functional analysis of the VHL tumour suppressor gene function by comparative genome analysis,"C Morrissey, ER Woodward, SC Clifford, LD Hurst, NA Affara, ...","JOURNAL OF MEDICAL GENETICS 36, S26-S26",,0,1999
Mutation analysis of the patched promoter region and alternative 5′ exons in naevoid basal cell carcinoma syndrome (Gorlin syndrome),"S Rooker, C Hardy, P Fullwood, R Toftgard, P Kogerman, PA Farndon, ...","Journal of Medical Genetics 36, S98",,0,1999
Identification Of Ext1 And Ext2 Gene Mutations In Families With Hereditary Multiple Exostoses,"FM Richards, MH Rajpar, CH Gerrand, TR Cole, PA Farndon","The Journal of Bone and Joint Surgery-british Volume 81, 328",,0,1999
Functional analysis of the VHL tumour suppressor gene function by compae genome analysis,"C Morrissey, ER Woodward, SC Clifford, LD Hurst, NA Affara, ...","JOURNAL OF MEDICAL GENETICS 36, SP41-SP41",,0,1999
Molecular genetic analysis of von Hippel-Lindau (VHL) disease,"ER Maher, P Rehal, R McMahon, S Rose, S Littleboy, FM Richards, ...","Journal of Medical Genetics 35 (1S), 23S",,0,1998
Identification of EXT1 and EXT2 gene mutations in families with Hereditary Multiple Exostoses,"FM Richards, MH Rajpar, C Gerrand, TRP Cole","Journal of Medical Genetics 35 (1S), 44S",,0,1998
SP61 Identification of EXT2 gene mutations in families with Hereditary Multiple Exostoses,"W Mitchell, FM Richards, M Gattas, TRP Cole","Journal of Medical Genetics 34 (9S), 28S",,0,1997
Mapping the Multiple Self-Healing Squamous Epithelioma (MSSE) gene and investigation of Patched (PTCH) as a candidate gene.,"FM Richards, DR Goudie, Q Jene, MA FergusonSmith","JOURNAL OF MEDICAL GENETICS 34, SP62-SP62",,0,1997
Identification of EXT2 gene mutations in families with Hereditary Multiple Exostoses,"W Mitchell, FM Richards, M Gattas, TRP Cole, PA Farndon","JOURNAL OF MEDICAL GENETICS 34, SP61-SP61",,0,1997
Phenotypic expression in von Hippel-Lindau disease correlations with germline VHL gene mutations.,"AR Webster, ER Maher, FM Richards, S Green, PA Crossey, AT Moore","INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 37 (3), 5238-5238",,0,1996
GENOTYPE-PHENOTYPE CORRELATIONS IN VONHIPPEL-LINDAU (VHL)-DISEASE,"PA CROSSEY, FM RICHARDS, JS GREEN, HPH NEUMANN, K FOSTER, ...","JOURNAL OF MEDICAL GENETICS 32 (2), 137-138",,0,1995
Genotype-phenotype correlations in von Hippel-Lindau (VHL) disease: Predisposition to pheochromocytoma,"ER Maher, PA Crossey, FM Richards",American Journal of Human Genetics 55 (CONF-941009--),,0,1994
MOLECULAR-CLONING OF THE VONHIPPEL-LINDAU TUMOR-SUPPRESSOR GENE,"MI LERMAN, F LATIF, K TORY, J GNARRA, M YAO, FM DUH, ...","CYTOGENETICS AND CELL GENETICS 65 (1-2), 41-41",,0,1994
GENETIC-LINKAGE BETWEEN VONHIPPEL-LINDAU (VHL) DISEASE AND 3 MICROSATELLITE POLYMORPHISMS REFINES THE LOCALIZATION OF THE VHL LOCUS,"PA CROSSEY, FM RICHARDS, F LATIF, MH JONES, ME PHIPPS, ...","CYTOGENETICS AND CELL GENETICS 65 (1-2), 35-36",,0,1994
PHYSICAL MAPPING OF CHROMOSOME-3P25-P26 BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH),"ME PHIPPS, FM RICHARDS, NA AFFARA, F LATIF, MA LEVERSHA, ...","CYTOGENETICS AND CELL GENETICS 65 (1-2), 44-44",,0,1994
FREQUENT GERMLINE DELETIONS IN VONHIPPEL-LINDAU DISEASE,"FM RICHARDS, PA CROSSEY, F LATIF, K FOSTER, M LINEHAN, ...","AMERICAN JOURNAL OF HUMAN GENETICS 53 (3), 24-24",,0,1993
MOLECULAR CHARACTERIZATION OF GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE GENE,"PA CROSSEY, FM RICHARDS, LATIF, K FOSTER, M LINEHAN, ...","AMERICAN JOURNAL OF HUMAN GENETICS 53 (3), 25-25",,0,1993
"DETAILED GENETIC-MAPPING OF THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE (VOL 30, PG 104, 1993)","FM RICHARDS, ER MAHER, F LATIF, ME PHIPPS, K TORY, M LUSH, ...","JOURNAL OF MEDICAL GENETICS 30 (6), 528-528",,0,1993
HEAT-SHOCK AND OTHER AGENTS WHICH INDUCE THERMOTOLERANCE BRING ABOUT THE TERMINAL DIFFERENTIATION OF HL-60 HUMAN PROMYELOCYTIC LEUKEMIA-CELLS,"FM RICHARDS, JA HICKMAN","BRITISH JOURNAL OF CANCER 56 (2), 197-197",,0,1987
INVESTIGATIONS OF THE INVOLVEMENT OF A STRESS RESPONSE IN THE PROMOTION OF DIFFERENTIATION OF HL-60 CELLS,"JA Hickman, FM Richards","PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 28, 46-46",,0,1987
Studies of the induction of tumour cell terminal differentiation,FM Richards,University of Aston in Birmingham,,0,1987
Supplementary information “The EGFR demonstrates linear signal transmission”,"DA Oyarzún, JL Bramhall, F López-Caamal, FM Richards, DI Jodrell, ...",,,0,0
Prognostic factors in renal cell carcinoma,"T Stackhouse, I Kuzmin, W Modi, L Geil, L Schmidt, F Zhou, H Li, MH Wie, ...","Arch Dermatol 135, 1195-1202",,0,0
Supplemental Information,"CA Watts, FM Richards, A Bender, PJ Bond, O Korb, O Kern, M Riddick, ...",,,0,0
Cosegregation of schizophrenia with Becker muscular dystrophy: susceptibility locus for,"ST Warren, BA Oostra, FM Richards, ER Maher, M FLatif, KH Gustavson, ...",,,0,0
MST2 dependent actin-microtubule interaction is required for tumour invasion and oncogene YAP activation in oral squamous cell cancer (oSCC),"C Escriu, K Mulder, S Woodhouse, N Benaich, S Broad, F Richards, ...",,,0,0
"Intemational Journal of Pharmaceutics, 62 (1990) 269-270","C Ahlneck, G Zografi, HO Alpar, AM Bason, JA Hickman, FM Richards, ...",,,0,0
"Familial gastric cancer: overview and guidelines for management* Carlos Caldas, Fatima Carneiro","HT Lynch, J Yokota, GL Wiesner, SM Powell, FR Lewis, DG Huntsman, ...",,,0,0
